Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-episode schizophrenia. A Clinical Perspective

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F12%3A%230001662" target="_blank" >RIV/65269705:_____/12:#0001662 - isvavai.cz</a>

Alternative codes found

RIV/00216224:14740/12:00059859

Result on the web

<a href="http://dx.doi.org/10.1155/2012/764769" target="_blank" >http://dx.doi.org/10.1155/2012/764769</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1155/2012/764769" target="_blank" >10.1155/2012/764769</a>

Result language

angličtina

Original language name

Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-episode schizophrenia. A Clinical Perspective

Original language description

Approximately 80% of patients with the first-episode schizophrenia reach symptomatic remission after antipsychotic therapy. However, within two years most of them relapse, mainly due to low levels of insight into the illness and nonadherence to their oral medication. Therefore, although the formal data available is limited, many experts recommend prescribing long-acting injectable second-generation antipsychotics (mostly risperidone or alternatively paliperidone) in the early stages of schizophrenia, particularly in patients who have benefited from the original oral molecule in the past and agree to receive long-term injectable treatment. Early application of long-acting injectable second-generation antipsychotics can significantly reduce the risk of relapse in the future and thus improve not only the social and working potential of patients with schizophrenia but also their quality of life.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FL - Psychiatry, sexology

OECD FORD branch

—

Project

<a href="/en/project/ED1.1.00%2F02.0068" target="_blank" >ED1.1.00/02.0068: Central european institute of technology</a><br>

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Schizophrenia Research and Treatment

ISSN

2090-2085

e-ISSN

—

Volume of the periodical

2012

Issue of the periodical within the volume

764769

Country of publishing house

EG - EGYPT

Number of pages

7

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—